COVID-19: Can India vaccinate all adults in 4 months?
Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers
Some ASHA workers refused to get the jab on Saturday
COVID-19: Expert committee approves Covaxin for children aged 2-18 years
No data on clinical trials of Bharat Biotech vaccine on children available publicly yet
Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines
Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss
First ‘Made in India’ cervical cancer vaccine in offing
Vaccine to be launched after adequate doses manufactured for distribution
Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates
Share of population completely vaccinated grew just 5 percentage points since April
Vaccine Scarcity: Government projection of vaccine demand goes haywire
Not expecting second surge, Centre exported more than 60 million doses
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
India launches vaccine against Japanese encephalitis
Can the indigenously developed JENVAC curb spread of brain fever?
Indian rotavirus vaccine found effective during clinical trial
Rotovac costs fifty times less than brands sold by global pharma companies
Bharat Biotech’s vaccine, Covaxin not as effective as Serum Institutes of India’s Covishield
Study led by National Centre for Biological Sciences intended to shape future vaccine strategies by offering insights into the immunity acquired …
Between hype and hope on Zika
Bharat Biotech's patent claim on vaccines to fight Zika is riddled with holes and rivals abroad are surging ahead
Viva Cuba for its vaccine revolution
Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world
Covaxin has not got emergency use approval from WHO since 6 months. Know the process here
The approval is stuck in the final fifth stage of the process when clinical data on safety, efficacy, quality and risk management plan are evaluated
Confronting head-on the vexed pricing of COVID -19 vaccines
It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population
WHO finally gives emergency use nod for Covaxin
Those administered indigenous Indian vaccine against COVID-19 can now travel abroad unhindred
Bhopal Covaxin trial participants allege side-effects, irregularities
Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there
Moderna’s brazen patent grab on a COVID-19 jab
The US administration is finally putting its foot down on the appropriation of public research by drug firms
The world may soon get a vaccine against Chikungunya
A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute in partnership with Bharat Biotech …
India readies for COVID-19 vaccination but vexed questions on the solution remain
The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …
Bharat Biotech will begin clinical trials of Covaxin on 2-18 age group
The clinical trials will be conducted to evaluate Covaxin’s safety and efficacy on a population group left out of India’s current …
COVID-19 vaccines for all: India’s supply story deconstructed
Vaccination presents a way out of the COVID-19 mess India has landed in; but jabs are in short supply and there’s no clarity …
Vaccine production in South Africa: how an industry in its infancy can be developed
Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity
COVID vaccines: How to make sense of reports on their effectiveness
Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants
Delaying the second COVID-19 vaccine dose: A medical expert answers key questions
The uncertainty is around how long the protective effect of the first dose will last without a second shot